Allergic bronchopulmonary aspergillosis in patients with Cystic Fibrosis




Cystic fibrosis; Aspergillus fumigatus; Allergic bronchopulmonary aspergillosis.


Cystic fibrosis (CF) is a genetic disease of autosomal recessive profile and is characterized by dysfunction of the CFTR gene, which will affect some organs such as the lungs, pancreas, liver, intestines, and testes, with the lungs being the most characteristic. Such changes are capable of causing consistent obstructions due to the viscous mucus produced. Infections are a recurrent factor in carriers of this disease due to the presence of secretion, becoming an ideal environment for the propagation of microorganisms, such as fungi and bacteria, which can colonize the airways of patients and bring about an aggravation, worsening the patient's clinical picture. This is the case of the fungus Aspergillus fumigattus, the cause of allergic bronchopulmonary aspergillosis (ABPA), which can lead to relevant complications, especially in lung function. Analyzing the factors that make CF patients more likely to contract ABPA and how this can worsen their clinical condition, searching for materials from the PUBMED and SCIELO platforms, using the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), the results obtained in this study show that the presence of ABPA in cystic fibrosis patients brings increased microbial colonization, lung deterioration, poorer nutritional status, and greater respiratory obstruction by mucus that causes a greater increase in hospitalization.


Aguiar, S. S., Damaceno, N. & Forte, W. C. N. (2017). Tests to assess sensitization to Aspergillus fumigatus in cystic fibrosis. Revista Paulista de Pediatria, 35(3), 252–257.;2017;35;3;00003

Agarwal, R. (2012). Aspergilose broncopulmonar alérgica - tratamento. American Review Of Respiratory Disease, 2–3.

Almeida, M. B., Bussamra, M. H. C. F. & Rodrigues, J. C. (2006). ABPA diagnosis in cystic fibrosis patients: The clinical utility of IgE specific to recombinant Aspergillus fumigatus allergens. Jornal de Pediatria, 82(3), 215–220.

Alyasin, S., Moghtaderi, M., Farjadian, S., Babaei, M. & Hosseini Teshnizi, S. (2018). Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis. Electronic Physician, 10(1), 6273–6278.

Breuer, O., Schultz, A., Garratt, L. W., Turkovic, L., Rosenow, T., Murray, C. P., Karpievitch, Y. V., Akesson, L., Dalton, S., Sly, P. D., Ranganathan, S., Stick, S. M. & Caudri, D. (2020). Aspergillus infections and progression of structural lung disease in children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 201(6), 688–696.

Carneiro, A. C. C., Lemos, A. C. M., Arruda, S. M. & Santana, M. A. P. S. (2008). Prevalência de aspergilose broncopulmonar alérgica em pacientes com fibrose cística na Bahia, Brasil. Jornal Brasileiro de Pneumologia, 34(11), 900–906.

César, M. & Castro, S. De. (2011). O Tratamento na Fibrose Cística e suas Complicações. Revista Hospital Universitário Pedro Ernesto, 10(4).

Firmida, M. D. C. (2011). Fisiopatologia e Manifestações Clínicas da Fibrose Cística. Revista Hospital Universitário Pedro Ernesto, 10(4).

Hong, G., Psoter, K. J., Jennings, M. T., Merlo, C. A., Boyle, M. P., Hadjiliadis, D., Kawut, S. M. & Lechtzin, N. (2018). Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis. Journal of Cystic Fibrosis, 17(5), 624–630.

Hoffmann, A. & Procianoy, E. da F. A. (2011). Infecção respiratória na fibrose cística e tratamento. Clinical and Biomedical Research, 31(2).

Itens, P., Revis, R. & Uma, P. (2015). Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiologia e Serviços de Saúde, 24(2), 335–342.

Lattanzi, C., Messina, G., Fainardi, V., Tripodi, M. C., Pisi, G. & Esposito, S. (2020). Allergic bronchopulmonary aspergillosis in children with cystic fibrosis: An update on the newest diagnostic tools and therapeutic approaches. Pathogens, 9(9), 1–13.

Marmitt, D. J., Rempel, C., Goettert, M. I. & Silva, A. C. (2015). Plantas Medicinais da RENISUS Com Potencial Anti-inflamatório: Revisão Sistemática Em Três Bases de Dados Científicas. Revista Fitos, 9(2).

Maleki, M., Mortezaee, V., Hassanzad, M., Mahdaviani, S. A., Poorabdollah, M., Mehrian, P., Behnampour, N., Mirenayat, M. S., Abastabar, M., Tavakoli, M. & Hedayati, M. T. (2020). Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis patients using two different diagnostic criteria. European Annals of Allergy and Clinical Immunology, 52(3), 104–111.

Sancho-García, I. & Piñero-Zapata, M. (2021). Aumento de eventos cardiovasculares en pacientes tratados con clopidogrel y omeprazol simultáneamente: una revisión sistemática. Evidentia, 18, e12814.



How to Cite

SANTOS JÚNIOR, R. J. dos; SILVA, N. M.; SOUZA, P. G. V. D. de . Allergic bronchopulmonary aspergillosis in patients with Cystic Fibrosis. Research, Society and Development, [S. l.], v. 10, n. 7, p. e47610717227, 2021. DOI: 10.33448/rsd-v10i7.17227. Disponível em: Acesso em: 7 dec. 2023.



Review Article